Glivec in chronic myeloid leukemia - achievements, failures, problems

被引：0
|
作者：
Volkova, MA [1 ]
机构：
[1] NN Blokhin Oncol Res Ctr, Moscow, Russia
来源：
GEMATOLOGIYA I TRANSFUZIOLOGIYA | 2004年 / 49卷 / 02期
关键词：
chronic myeloid leukemia; glivec; leukemic cells; BCR-ABL gene;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：35 / 41
页数：7
相关论文
共 50 条
  • [1] Activity of granulocyte myeloperoxidase in chronic myeloid leukemia patients treated with Glivec®
    Juricic, G
    Podolar, S
    Sucic, M
    CLINICA CHIMICA ACTA, 2005, 355 : S350 - S350
  • [2] Therapeutic efficacy of imatinib mesilate (glivec) in a chronic phase of myeloid leukemia
    Turkina, AG
    Khoroshko, ND
    Druzhkova, GA
    Zingerman, BV
    Zakharova, ES
    Chelysheva, EY
    Vinogradova, OY
    Domracheva, EV
    Zakharova, AV
    Kovaleva, LG
    Kolosheinova, TL
    Kolosova, LY
    Zhuravleva, VS
    Tikhonova, LY
    TERAPEVTICHESKII ARKHIV, 2003, 75 (08) : 62 - 67
  • [3] The use of Glivec in chronic myeloid leukemia: Report of 10 cases in a single institution
    Vasilica, M
    Stoia, R
    Georgescu, O
    Codreanu, V
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 96 - 96
  • [4] Treatment of residual disease in chronic myeloid leukemia with STI-571 (Glivec)
    Geissler, K
    Agis, H
    Sagaster, V
    ACTA MEDICA AUSTRIACA, 2002, 29 : 66 - 68
  • [5] Imatinib mesylate (Gleevec®/Glivec®):: A new therapy for chronic myeloid leukemia and other malignancies
    Hernández-Boluda, JC
    Cervantes, F
    DRUGS OF TODAY, 2002, 38 (09) : 601 - 613
  • [6] Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia - a Multicenter, Observational Study
    Pagnano, Katia B.
    Fava, Carmen
    Miranda, Eliana C.
    Bendit, Israel
    Seguro, Fernanda S.
    Magalhaes, Gustavo H. R.
    Clementino, Nelma D.
    Conchon, Monika
    Goncalves, Natalia N.
    Gaidano, Gianluca
    Lunghi, Monia
    Moellmann-Coelho, Arthur
    Luise, Ingrid
    Bergamaschi, Micaela
    Ferrero, Dario
    Centrone, Renato
    Pregno, Patrizia
    Fogliatto, Laura
    Giai, Valentina
    Dragani, Matteo Emidio
    Moiraghi, Elena
    Bortolini, Jaisson
    Castelli, Andrea
    Cuttica, Alessandra
    Bortolheiro, Teresa Cristina
    Pinna, Cristiane
    De Souza, Carmino Antonio
    Saglio, Giuseppe
    BLOOD, 2018, 132
  • [7] Which One, Generic Vs Original Glivec Is More Effective in Patients with Chronic Myeloid Leukemia?
    Kircali, Ekin
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Arslan, Onder
    Ozcan, Muhit
    Demirer, Taner
    Gurman, Gunhan
    Ilhan, Osman
    Akan, Hamdi
    Beksac, Meral
    Topcuoglu, Pervin
    BLOOD, 2019, 134
  • [8] Current Problems in the Management of Chronic Myeloid Leukemia in Turkey
    Demirkan, Fatih
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2011, 21 (02): : 24 - 28
  • [9] PLASMATIC LEVELS, RESPONSE AND TOLERANCE TO IMATINIB AFTER THE CHANGE OF GLIVEC TO GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE
    Wojnicz, A.
    Cornago Navascues, J.
    Vaitekovich, V.
    Mba, C.
    Sola Aparicio, E.
    Steegmann Olmedillas, J. L.
    HAEMATOLOGICA, 2018, 103 : 232 - 232
  • [10] Efficacy and Safety of Generic Imatinib Compared to Glivec in Chronic Phase - Chronic Myeloid Leukemia-Single Center Retrospective Analysis
    Bhatwadekar, Seema Shrinivas
    Deshpande, Shubhangi Vishwas
    Mehta, Arpan
    Shah, Parth
    BLOOD, 2019, 134
12345